Women’s Health Investment Report: Q1 2026 Funding, Exits and Market Analysis | FemmeHealth Alliance

Share This Post

FemmeHealth Alliance has produced its first quarterly capital intelligence report, a structured, source-attributed analysis of capital flows, exits, and market signals in women’s health, built for investors, allocators, and operators.

What Is Capital Intelligence?

Women’s health is attracting increasing institutional attention. Capital is moving, exits are happening, and the ecosystem is maturing. FHA is committed to providing the analytical infrastructure to read that activity clearly, to understand not just what happened, but what it signals, and where the next opportunity sits. FHA’s capital intelligence function exists to provide that layer. Each quarterly report draws on primary institutional data sources and FHA’s analytical framework to produce outputs that are precise, source-attributed, and decision-useful for a sophisticated audience.

What the Q1 2026 Report Contains

The inaugural report is structured across six sections:

  • Section 1 — The Exit Story: An analysis of the two transactions that defined Q1 2026 for this market and what they signal for allocators watching European platform assets.
  • Section 2 — The Broader Capital Environment: Where healthcare VC deployment and exit activity stood globally in Q1, drawn from PitchBook’s institutional research on biopharma and medtech.
  • Section 3 — The European Dimension: What the European venture data means for FHA’s primarily European audience, including the DACH region and the European life sciences exit picture.
  • Section 4 — What This Means for Allocators: FHA’s analytical layer — the structural argument, the patterns in the exit data, and five developments to watch in Q2 2026.
  • Section 5 — Company-Level Deal Flow: Women’s health transactions and fund closes from across the quarter, with FHA’s pattern analysis across sub-categories.
  • Section 6 — Methodology and Sources: Every primary source used, with publication dates and attribution.

A Note on What This Is

Q1 2026 produced two of the most significant women’s health transactions in recent memory. The full report analyses both in detail; the sequencing behind them, what they signal for the category. The data and the analysis are in the report.

Download the Q1 2026 Women’s Health Capital Intelligence Report

 

FHA publishes its capital intelligence report quarterly. The Q2 2026 edition will be published in August 2026. To receive it directly, enter your details below.

Subscribe To Our Newsletter

Get updates and stay connected

Scroll to Top